143 related articles for article (PubMed ID: 1970540)
21. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse.
Panagiotidis G; Salehi AA; Westermark P; Lundquist I
Diabetes Res Clin Pract; 1992 Dec; 18(3):167-71. PubMed ID: 1337737
[TBL] [Abstract][Full Text] [Related]
22. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
Ludvik B; Clodi M; Kautzky-Willer A; Schuller M; Graf H; Hartter E; Pacini G; Prager R
J Clin Invest; 1994 Nov; 94(5):2045-50. PubMed ID: 7962550
[TBL] [Abstract][Full Text] [Related]
23. Islet amyloid polypeptide (amylin) does not seem to be directly involved in the development of gestational diabetes mellitus.
Grigorakis SI; Alevizaki M; Rapti E; Anastasiou E; Alevizaki CC; Souvatzoglou A
Gynecol Obstet Invest; 1997; 44(1):6-10. PubMed ID: 9251946
[TBL] [Abstract][Full Text] [Related]
24. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
[TBL] [Abstract][Full Text] [Related]
25. Renal elimination of islet amyloid polypeptide.
Leckström A; Björklund K; Permert J; Larsson R; Westermark P
Biochem Biophys Res Commun; 1997 Oct; 239(1):265-8. PubMed ID: 9345307
[TBL] [Abstract][Full Text] [Related]
26. Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin.
Jamal H; Bretherton-Watt D; Suda K; Ghatei MA; Bloom SR
J Endocrinol; 1990 Sep; 126(3):425-9. PubMed ID: 2212934
[TBL] [Abstract][Full Text] [Related]
27. Lack of effect of islet amyloid polypeptide on hepatic glucose output in the in situ-perfused rat liver.
Nishimura S; Sanke T; Machida K; Bessho H; Hanabusa T; Nakai K; Nanjo K
Metabolism; 1992 Apr; 41(4):431-4. PubMed ID: 1556951
[TBL] [Abstract][Full Text] [Related]
28. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets.
Wang ZL; Bennet WM; Ghatei MA; Byfield PG; Smith DM; Bloom SR
Diabetes; 1993 Feb; 42(2):330-5. PubMed ID: 8425669
[TBL] [Abstract][Full Text] [Related]
29. Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats.
O'Brien TD; Westermark P; Johnson KH
Diabetes; 1991 Dec; 40(12):1701-6. PubMed ID: 1756910
[TBL] [Abstract][Full Text] [Related]
30. Islet amyloid polypeptide inhibits insulin secretion in conscious rats.
Fürnsinn C; Leuvenink H; Roden M; Nowotny P; Schneider B; Rohac M; Pieber T; Clodi M; Waldhäusl W
Am J Physiol; 1994 Aug; 267(2 Pt 1):E300-5. PubMed ID: 8074211
[TBL] [Abstract][Full Text] [Related]
31. Regulation of islet amyloid polypeptide in human pancreatic islets.
Novials A; Sarri Y; Casamitjana R; Rivera F; Gomis R
Diabetes; 1993 Oct; 42(10):1514-9. PubMed ID: 8375592
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects.
van Jaarsveld BC; Hackeng WH; Lips CJ; Erkelens DW
Diabet Med; 1993 May; 10(4):327-30. PubMed ID: 8508614
[TBL] [Abstract][Full Text] [Related]
33. Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats.
Pettersson M; Ahrén B
Acta Physiol Scand; 1990 Mar; 138(3):389-94. PubMed ID: 2183542
[TBL] [Abstract][Full Text] [Related]
34. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).
Gebre-Medhin S; Mulder H; Pekny M; Westermark G; Törnell J; Westermark P; Sundler F; Ahrén B; Betsholtz C
Biochem Biophys Res Commun; 1998 Sep; 250(2):271-7. PubMed ID: 9753619
[TBL] [Abstract][Full Text] [Related]
35. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
Spinas GA; Bock A; Keller U
Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
[TBL] [Abstract][Full Text] [Related]
36. Lack of effect of islet amyloid polypeptide in causing insulin resistance in conscious dogs during euglycemic clamp studies.
Kassir AA; Upadhyay AK; Lim TJ; Moossa AR; Olefsky JM
Diabetes; 1991 Aug; 40(8):998-1004. PubMed ID: 1860564
[TBL] [Abstract][Full Text] [Related]
37. Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats.
Mulder H; Ahrén B; Sundler F
Am J Physiol; 1996 Dec; 271(6 Pt 1):E1008-14. PubMed ID: 8997219
[TBL] [Abstract][Full Text] [Related]
38. Intra- and extracellular amyloid fibrils are formed in cultured pancreatic islets of transgenic mice expressing human islet amyloid polypeptide.
de Koning EJ; Morris ER; Hofhuis FM; Posthuma G; Höppener JW; Morris JF; Capel PJ; Clark A; Verbeek JS
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8467-71. PubMed ID: 8078905
[TBL] [Abstract][Full Text] [Related]
39. Effect of insulin treatment on circulating islet amyloid polypeptide in patients with NIDDM.
Lindström T; Leckström A; Westermark P; Arnqvist HJ
Diabet Med; 1997 Jun; 14(6):472-6. PubMed ID: 9212313
[TBL] [Abstract][Full Text] [Related]
40. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.
Kahn SE; D'Alessio DA; Schwartz MW; Fujimoto WY; Ensinck JW; Taborsky GJ; Porte D
Diabetes; 1990 May; 39(5):634-8. PubMed ID: 2185112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
